References
- Bchetnia M, Girard C, Duchaine C, et al. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review of the current global status. J Infect Public Health. 2020. DOI:10.1016/j.jiph.2020.07.011
- Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020. DOI:10.1001/jama.2020.4683
- Coronavirus Disease (COVID-19) Situation Reports. n.d. [cited 2020 Aug 6]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
- Estimating mortality from COVID-19. n.d. [cited 2020 Aug 6]. Available from: https://www.who.int/news-room/commentaries/detail/estimating-mortality-from-covid-19
- Primi risultati dell’indagine di sieroprevalenza sul SARS-CoV-2. 2020 [cited 2020 Aug 6]. Available from: https://www.istat.it/it/archivio/246156
- EpiCentro. Caratteristiche dei pazienti deceduti positivi all’infezione da SARS-CoV-2 in Italia. n.d. [cited 2020 Aug 6]. Available from: https://www.epicentro.iss.it/coronavirus/sars-cov-2-decessi-italia
- Pollán M, Pérez-Gómez B, Pastor-Barriuso R, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020;396(10250):535–544.
- Arora RK, Joseph A, Wyk JV, et al. SeroTracker: a global SARS-CoV-2 seroprevalence dashboard. Lancet Infect Dis. 2020. DOI:10.1016/S1473-3099(20)30631-9